Editor of Patient Care Online.
Study: AI-powered Intervention Led to Highest Reported Rate of T2D Remission to Date
ADA 2022: Patients with T2D who received a treatment intervention powered by artificial intelligence achieved a remission rate of more than 80%.
Dulaglutide Improves HbA1c for Youth with Type 2 Diabetes without Change in BMI
ADA 2022: "Breakthrough" findings may help to address the unmet need for additional treatment options for young patients with type 2 diabetes.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 6, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Younger Age and Higher HbA1c Among Factors Linked to CGM Uptake in New Study
ADA 2022: Younger age, insulin use, higher HbA1c, and higher diabetes distress were found to be associated with CGM uptake in prospective study.
Patients with Diabetes Up to 4-times More Likely to Develop Long COVID-19
ADA 2022: In a new literature review, 43% of studies included identified diabetes as a potent risk for developing post-acute sequelae of COVID-19.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 2, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 1, 2022
Heavy Alcohol Use Strongly Associated with Risk of Early-onset Colorectal Cancer, Study Finds
New research shows excessive alcohol use is strongly associated with an increased risk for colorectal cancer, regardless of genetic risk.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 31, 2022
CDC: Up to 1 in 5 Adult Survivors Experience Post-COVID Conditions
Compared to persons without evidence of prior infection, survivors are significantly more likely to experience conditions often attributable to post-COVID.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 25, 2022
Is There Room for TikTok in Medicine? A Young Clinician Explains
Lead author of a recent study discusses why clinicians may be hesitant to use TikTok and how social media may shape health care going forward.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
Three Doses of Pfizer’s COVID-19 Vaccine Well Tolerated in Children Under 5 Years of Age
Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 23, 2022
FDA Approved Dupilumab as the First Treatment for Eosinophilic Esophagitis
Dupilumab is approved for the treatment of eosinophilic esophagitis in patients aged ≥12 years weighing at least 40 kgs.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 20, 2022
NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half
In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.
Review of Biologic Treatments for Asthma Finds Inconsistent Effects on Airway Hyperresponsiveness
ATS 2022: Findings from a literature review provide insight into the mechanisms of airway hyperresponsiveness in asthma.
Tezepelumab Reduces Asthma Exacerbations by More than Half, Reports NAVIGATOR Study Author
Njira Lugogo, MD, sat down with Patient Care Online to discuss findings from the prespecified exploratory analysis of the NAVIGATOR study that she presented at ATS 2022.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 18, 2022
Real-world Data Showed Mepolizumab Reduced Exacerbations, Oral Corticosteroid Use in Adults with Severe Asthma
ATS 2022: Mepolizumab was effective in reducing asthma exacerbations and oral corticosteroid use in real-world clinical practice, according to new research.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 17, 2022
NAVIGATOR Data Presented at ATS 2022 Show Improved Clinical Responses to Treatment with Tezepelumab vs Placebo
ATS 2022. A greater proportion of tezepelumab-treated patients with severe, uncontrolled asthma achieved on-treatment clinical responses than placebo-treated patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 16, 2022
Quality of HTN-related Videos on TikTok: Study Author Shares Findings
Lead author of a recent study sat down with Patient Care to discuss how clinicians are using the popular video sharing app and the quality of content available.
National Survey Finds Primary Care in Crisis
Primary care clinician burnout is at an all-time high and 25% of clinicians plan to leave within the next 3 years, according to a recent US survey.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 12, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 11, 2022
